Skip to main content

Advertisement

SpringerLink
Log in

The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

The role of regional lymph node dissection (LND) in surgical management of high-grade, invasive transitional cell carcinoma of the bladder has evolved over the past several decades. The current concepts and rationale for LND in patients undergoing radical cystectomy for bladder cancer are reviewed and discussed. Evidence suggests that a more extended LND (with cephalad extent to include at least the common iliac vessels) for lymph node-positive and-negative patients undergoing radical cystectomy for bladder cancer may provide therapeutic benefits in addition to prognostic information. Lymph node density also provides risk stratification for lymph node-positive patients and may reduce the surgical bias and extent of the LND, both of which are currently not standardized. Although the absolute limits of the LND remain to be determined, an evolving body of data supports a more extended LND at the time of cystectomy in appropriate surgical candidates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2005. CA: Cancer J Clin 2006, 56:106–130.

    Article  Google Scholar 

  2. Prout G, Marshall VF: The prognosis with untreated bladder tumors. Cancer 1956, 9:551–558.

    Article  PubMed  CAS  Google Scholar 

  3. Stein JP: Indications for early cystectomy. Urology 2003, 62:591–595.

    Article  PubMed  Google Scholar 

  4. Stein JP, Lieskovsky G, Cote R, et al.: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001, 19:666–675.

    PubMed  CAS  Google Scholar 

  5. Leissner J, Ghoneim MA, Abol-Enein H, et al.: Extended radical LND in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 2004, 171:139–144.

    Article  PubMed  CAS  Google Scholar 

  6. Poulsen AL, Horn T, Steven K: Radical cystectomy; extending limits of pelvic LND improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998, 160:2015–2020, 1998.

    Article  PubMed  CAS  Google Scholar 

  7. Vieweg J, Gschwend JE, Herr HW, Fair WR: The impact of primary stage on survival in patients with lymph node positive bladder cancer. J Urol 1999, 161:72–76.

    Article  PubMed  CAS  Google Scholar 

  8. Leissner J, Hohenfellner R, Thuroff JW, Wolf HK: LND in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 2000, 85:817–823.

    Article  PubMed  CAS  Google Scholar 

  9. Vazina A, Dugi D, Shariat SF, et al.: Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 2004, 171:1830–1834.

    Article  PubMed  Google Scholar 

  10. Abdel-Latif M, Abol-Enein H, El-Baz M, Ghoneim MA: Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol 2004, 172:85–89.

    Article  PubMed  Google Scholar 

  11. Cheng CW, Ng CF, Chan CK, et al.: A fourteen-year review of radical cystectomy for transitional cell carcinoma demonstrating the usefulness of the concept of lymph node density. Int Braz J Urol 2006, 32:536–449.

    Article  PubMed  Google Scholar 

  12. Hautmann RE, Gschwend JE, de Petriconi RC, et al.: Cystectomy for transitional cell carcinoma of the bladder: results of a surgery-only series in the neobladder era. J Urol 2006, 176:486–492.

    Article  PubMed  Google Scholar 

  13. Madersbacher S, Hochreiter W, Burkhard F, et al.: Radical cystectomy for bladder cancer today-a homogenous series without neoadjuvant therapy. J Clin Oncol 2003, 21:690–686.

    Article  PubMed  Google Scholar 

  14. Montie JE: Against bladder sparing: surgery. J Urol 1999, 162:452–455.

    Article  PubMed  CAS  Google Scholar 

  15. Lebret T, Herve J-M, Lyonneau L, et al.: After cystectomy, is it justified to perform a bladder replacement for patients with lymph node positive bladder cancer? Eur Urol 2002, 42:344–349.

    Article  PubMed  Google Scholar 

  16. Stein JP, Quek ML, Skinner DG: Lymphadenectomy for invasive bladder cancer: I. Historical perspective and contemporary rationale. BJU Int 2006, 97:227–231.

    Article  PubMed  Google Scholar 

  17. Stein JP, Quek ML, Skinner DG: Lymphadenectomy for invasive bladder cancer. II. Technical aspects and prognostic factors. BJU Int 2006, 97:232–237.

    Article  PubMed  Google Scholar 

  18. Barth PJ, Gerharz EW, Ramaswamy A, et al.: The influence of lymph node counts on the detection of pelvic lymph node metastasis in prostate cancer. Pathol Res Pract 1999, 195:633–636.

    PubMed  CAS  Google Scholar 

  19. Terrone C, Guercio S, DeLuca S, et al.: The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int 2003, 91:37–40.

    Article  PubMed  CAS  Google Scholar 

  20. Smith JA, Whitmore WF Jr: Regional lymph node metastasis from bladder cancer. J Urol 1981, 126:591–593.

    PubMed  Google Scholar 

  21. Bochner BH, Cho C, Herr HW, et al.: Prospective packaged LNDs with radical cystectomy: evaluation of node count variability and node mapping. J Urol 2004, 172:1286–1290.

    Article  PubMed  Google Scholar 

  22. Abol-Enein H, El-Baz M, Abd El-Hameed MA, et al.: Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study-a single center experience. J Urol 2004, 172:11818–1821.

    Google Scholar 

  23. Stein JP, Cai J, Groshen S, Skinner DG: Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic LND: the concept of lymph node density. J Urol 2003, 170:35–41.

    Article  PubMed  Google Scholar 

  24. Bochner BH, Herr HW, Reuter VE: Impact of separate versus en bloc pelvic LND on the number of lymph nodes retrieved in cystectomy specimens. J Urol 2001, 166:2295–2296.

    Article  PubMed  CAS  Google Scholar 

  25. Stein JP, Penson DF, Cai J, et al.: Radical cystectomy with an extended lymphadenectomy-evaluating separate package versus en bloc submission in node-positive bladder cancer. J Urol 2007, 177:876–881.

    Article  PubMed  Google Scholar 

  26. Grossman HB, Natale RB, Tangen CM, et al.: Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003, 349:859–866.

    Article  PubMed  CAS  Google Scholar 

  27. Herr HW, Faulkner JR, Grossman HB, et al.: Surgical factors influence bladder outcomes: a cooperative group report. J Clin Oncol 2004, 22:2781–2789.

    Article  PubMed  Google Scholar 

  28. Eastham JA, Kattan MW, Riedel E, et al.: Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol 2003, 170:2292–2295.

    Article  PubMed  Google Scholar 

  29. Konety BR, Joslyn SA, O’Donnell MA: Extent of pelvic LND and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the surveillance, epidemiology and end results program data bade. J Urol 2003, 169:945–50.

    Article  Google Scholar 

  30. Herr H, Lee C, Chang S, Lerner S, For the Bladder Cancer Collaborative Group: Standardization of radical cystectomy and pelvic LND for bladder cancer; a collaborative group report. J Urol 2004, 171:1823–1828.

    Article  PubMed  Google Scholar 

  31. Brossner C, Pycha A, Toth A, et al.: Does extended LND increase the morbidity of radical cystectomy? BJU Int 2004, 93:64–66.

    Article  PubMed  CAS  Google Scholar 

  32. Queck MI, Stein JP, Clark PE, et al.: Microscopic and gross extravesical extension in pathologic staging of bladder cancer. J Urol. 2004, 171:640–645.

    Article  Google Scholar 

  33. Lerner SP, Skinner DG, Lieskovsky G, et al.: The rationale for en bloc pelvic LND for bladder cancer patients with nodal metastases: long-term results. J Urol 1993, 149:758–764.

    PubMed  CAS  Google Scholar 

  34. Vieweg J, Gschwend JE, Herr HW, Fair WR: Pelvic LND can be curative in patients with node positive bladder cancer, J Urol 1999, 161:449–454.

    Article  PubMed  CAS  Google Scholar 

  35. Herr HW: Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003, 169:943–945.

    Article  PubMed  Google Scholar 

  36. Frank I, Cheville JC, Blute ML, et al.: Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy. Cancer 2003, 97:2425–2431.

    Article  PubMed  Google Scholar 

  37. Knap MM, Lundbeck F, Overgaard J: The role of pelvic LND as a predictive and prognostic factor in bladder cancer. Eur J Cancer 2003, 39:604–613.

    Article  PubMed  CAS  Google Scholar 

  38. Vieweg J, Whitmore WF Jr, Herr HW, et al.: The role of pelvic LND and radical cystectomy for lymph node positive bladder cancer. Cancer 1994, 73:3020–3028.

    Article  PubMed  CAS  Google Scholar 

  39. Herr HW, Bochner BH, Dalbagni G, et al.: Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002, 167:1295–1298.

    Article  PubMed  Google Scholar 

  40. Herr HW: Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 2003, 61:105–108.

    Article  PubMed  Google Scholar 

  41. Honma I, Masumori N, Sato E, et al.: Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer-analysis of role of pelvic LND. Urology 2006, 68: 543–548.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, 1441 Eastlake Avenue, Suite 7416, Los Angeles, CA, 90089, USA

    John P. Stein MD

Authors
  1. John P. Stein MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John P. Stein MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stein, J.P. The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer. Curr Oncol Rep 9, 213–221 (2007). https://doi.org/10.1007/s11912-007-0024-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-007-0024-1

Keywords

Search

Navigation